Enzymatic C42 Diversification of Rapamycin Identifies a Potent Butyryl-Modified Anticancer Derivative

Journal:
Organic Letters
Published:
DOI:
10.1021/acs.orglett.6c00072
Affiliations:
3
Authors:
6
Go to article
Institutions Authors Share
University of Chinese Academy of Sciences (UCAS), China
4.000000
 0.67
State Key Laboratory of Chemical Biology, SIOC CAS, China
1.500000
 0.25
MOE Key Laboratory of Basic Pharmacology, ZMU, China
0.500000
 0.08
Interested in Microbiology?